Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 22Terminated 16Recruiting 8Active not recruiting 6Unknown 5Withdrawn 3Not yet recruiting 2Available 2Approved for marketing 1

Sponsor Class

OTHER 28NIH 21INDUSTRY 5OTHER_GOV 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 5Sarcoma 2Thoracic 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1Endocrine 1

Conditions

Neoplasms 183Breast Neoplasms 174Carcinoma, Non-Small-Cell Lung 173Colorectal Neoplasms 105Stomach Neoplasms 81Pancreatic Neoplasms 79Lung Neoplasms 79Prostatic Neoplasms 77Melanoma 68Neoplasm Metastasis 67Recurrence 66Leukemia, Myeloid, Acute 66Multiple Myeloma 64Ovarian Neoplasms 62Carcinoma, Hepatocellular 62Lymphoma 61Advanced Solid Tumor 61Advanced Solid Tumors 56Solid Tumor 50Uterine Cervical Neoplasms 48Lymphoma, Non-Hodgkin 48Glioblastoma 44Lymphoma, B-Cell 40Leukemia 39Colonic Neoplasms 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Head and Neck Neoplasms 33Esophageal Neoplasms 32Urinary Bladder Neoplasms 30Sarcoma 30

Interventions

Vorinostat 1Biological Factors 13-Iodobenzylguanidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Neuroblastoma × Clear all
NCT05782959 2023-03-24

Phase 1 Study of BCD-245 in Subjects With Neuroblastoma

Biocad

Phase 1 Unknown
24 enrolled
CNS

Neuroblastoma

NCT03561259 2023-02-16

OPTIMUM

Jubilant DraxImage Inc.

Phase 2 Unknown
60 enrolled
CNS

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT04864821 2021-05-06

Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid Tumor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Phase EARLY_PHASE1 Unknown
24 enrolled
CNSGastrointestinalSarcomaThoracic

Lung Neoplasms, Neuroblastoma, Osteosarcoma, Stomach Neoplasms

NCT02919046 2017-03-14

Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children

Sinobioway Cell Therapy Co., Ltd.

Phase NA Unknown
22 enrolled
CNS

Neuroblastoma, Recurrence

NCT00314925 2010-02-25

Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

Neotropix

Phase 1 Unknown
60 enrolled
CNSEndocrineGenitourinaryOther solid neoplasmSarcoma

Carcinoid Tumor, Glioblastoma, Medulloblastoma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Rhabdomyosarcoma, Alveolar

Data powered by HemOnc (CC BY 4.0) Colophon âš¡